Tesamorelin Reconstitution Vial Size, BAC Water, and Dose Volumes Vial Size 2 mg BAC Water 0.5 mL Concentration 4,000 mcg/mL 1 mg Dose 0.25 mL (25 units) 1.4 mg Dose 0.35 mL (35 units) 2 mg Dose 0.50 mL (50 units, full vial) Vial Size 2 mg BAC Water 1.0 mL Concentration 2,000 mcg/mL 1 mg Dose 0.50 mL (50 units) 1.4 mg Dose 0.70 mL (70 units) 2 mg Dose 1.0 mL (100 units, full vial) Vial Size 5 mg BAC Water 1.0 mL Concentration 5,000 mcg/mL 1 mg Dose 0.20 mL (20 units) 1.4 mg Dose 0.28 mL (28 units) 2 mg Dose 0.40 mL (40 units) Vial Size 5 mg BAC Water 2.5 mL Concentration 2,000 mcg/mL 1 mg Dose 0.50 mL (50 units) 1.4 mg Dose 0.70 mL (70 units) 2 mg Dose 1.0 mL (100 units) Vial Size 10 mg BAC Water 2.0 mL Concentration 5,000 mcg/mL 1 mg Dose 0.20 mL (20 units) 1.4 mg Dose 0.28 mL (28 units) 2 mg Dose 0.40 mL (40 units) Vial Size 10 mg BAC Water 5.0 mL Concentration 2,000 mcg/mL 1 mg Dose 0.50 mL (50 units) 1.4 mg Dose 0.70 mL (70 units) 2 mg Dose 1.0 mL (100 units) U-100 insulin syringes have 100 units = 1.0 mL

Reported Benefits of BPC-157: Accelerated Healing: Studies suggest that BPC-157 may accelerate healing of wounds, muscles, tendons, and nerves
According to William Hinojosa, DO, a general surgeon with Oklahoma Surgical Associates, the benefits of GLP-1 medications are significant, but its important for patients to understand potential side effects, especially as their use becomes more widespread
The number of patients included in the studies ranges from 1 (case report) to 440.089, with a median of 355 (IQR 1295) subjects